Browse > Article

Clinical Significance of the Expression of p53, p21, EGFR and c-erbB-2 in Squamous Cell Carcinoma of the Head and Neck  

Lee Jun-Han (Department of Otolaryngology-Head and Neck Surgery, College of Medicine, Chosun University)
Do Nam-Yong (Department of Otolaryngology-Head and Neck Surgery, College of Medicine, Chosun University)
Park Sung-Yong (Department of Otolaryngology-Head and Neck Surgery, College of Medicine, Chosun University)
Kim Gun-Hyung (Department of Otolaryngology-Head and Neck Surgery, College of Medicine, Chosun University)
Cho Sung-Il (Department of Otolaryngology-Head and Neck Surgery, College of Medicine, Chosun University)
Publication Information
Korean Journal of Head & Neck Oncology / v.21, no.2, 2005 , pp. 139-145 More about this Journal
Abstract
Background and Objectives: Because of squamous cell carcinoma of the head and neck undergoes a generally poor hospital course, the prognostic significance of the squamous cell carcinomas in head and neck have been evaluated to identify those features associated with aggressive biologic behavior according to the immunologic and histopathologic characteristics. Materials and Method: To assess the significance of EGFR, c-erbB-2, p21 and p53 protein in head and neck tumors and their correlation with prognostic factors, samples from 74 patients with squamous cell carcinomas of larynx, pharynx, and oral cavity were studied immunohistochemically. Results: EGFR, c-erbB-2, p21, and p53 protein were expressed 94.6%, 24.3%, 85.1%, and 55.4% in 74 cases of head and neck squamous cell carcinoma, respectively. The positive expression of EGFR was associated significantly with clinical stage and the negative expressions of p21 was associated significantly with histopathologic differentiation. There were no significant relationships between the reactivity of EGFR, c-erbB-2, p21, and p53 protein. Conclusion: The expression of EGFR, c-erbB-2, p21 and p53 protein could be related to oncogenesis, and the expression of p21 and EGFR protein can be used as a prognosticator in head and neck squamous cell carcinoma under certain limitations, but c-erbB-2 and p53 protein expression alone is not enough for evaluating prognosis of the carcinoma.
Keywords
EGFR; c-erbB-2; p21 protein; p53 protein;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Field JK, Malliri A, Butt SA: P53 overexpression in the stage squamous cell carcinoma of the head and neck: Correlation with a very poor clinical outcome. Int J Oncol. 1993;3:431-435
2 Fujimoto K, Yamada Y, Okajima E: Frequent association of p53 gene mutation in invasive bladder cancer. Cancer Res. 1992; 52: 1393-1398
3 Samanta A, LeVea CM, Dougall WC, Qian X, Greene MI: Ligand and p185c-neu density govern receptor interactions and tyrosine kinase activation: Receptor dimerization interaction of p185c-neu receptors neu activation factor. Pro Natal Acad Sci U.S.A. 1994:91:1711-1715   DOI   ScienceOn
4 Santini J, Formento JL, Francoul M, et al: Characterization, quantification, and potential clinical value of the epidermal growth factor receptor in head and neck squamous cell carcinomas. Head & Neck. 1991;13:132-139   DOI   ScienceOn
5 Ishtoya J, Toriyama M, Oguchi N; Gene amplification and over-expression of EGF receptor in squanwus cell carcinonws of the head and neck. Br J Cancer. 1989:59:559-563   DOI   ScienceOn
6 Dergham ST, Dugan MC, Joshi US, et al: The clinical significance of p21 (WAFI/CIP-l) and p53 expression in pancreatic adenocarcinoma. Cancer. 1997;80:372-381   DOI   PUBMED   ScienceOn
7 Kim SH, Chung DH, Yeom BW: Expression of p53 and nm23-HI protein in laryngeal squamous cell carcinoma. Korea J Otolaryngol. 1996;39:265-272
8 Jung KY, Choi JO: Clinical significance of the expression of oncosuppressor gene proteins and epidermal growth factor receptor in squmous cell carcinoma of the larynx. Korean J Otolaryngol 1993;36:990-1004
9 Reynolds FH, Todaro GJ, Fryling C, et al: Human transforming growth factor induce tyrosine phosphorylation of EGF receptors. Nature. 1981;292:259-262   DOI   ScienceOn
10 Bartek J, Bartkova J, Vojtes B, et al: Patterns of expression of the p53 tumor suppressor in human breast tissues and tumors in situ and in vitro. Int J Caner. 1990;40:839-844
11 Hendler FJ, Ozanne BW: Human squamous cell lung cancers express increased epidermal growth factor receptors. J Clin Invest. 1984;74:647-651   DOI   ScienceOn
12 Tahara E: Growth factors and oncogenes in human gastric carcinoma. J Cancer Res. 1990;116:121-128   DOI   PUBMED
13 Costa S, Stamm H, Almendral A: Predictive value of EGFR in breast cancer. Lancet. 1988:26: 1258-1264
14 Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL: Human breast cancer: Correlation of relapse and survival with amplification of the Her-2/neu oncogene. Science. 1987: 235:177-182   DOI   PUBMED
15 Schecter AL, Hung MC, Vaidyanathan L, et al: The neu gene: An erbB-homologous gene distinct from and unlinked to the gene encoding the EGF receptor. Science. 1985:229:976-978   DOI   PUBMED
16 Barbareschi M, Leonnardi E, Mauri FA, Serio G, Dalla Palma P: P53 and c-erbB-2 protein expression in breast carcinomas: An immunohistochemical study including correlations with receptor status, proliferation markers, and clinical stage in human breast cancer. Am J Clin Pathol. 1992:98:408-418   DOI
17 Yasui W, Sumiyoshi H, Hata J, et al: Expression of epidermal growth factor receptors in human gastric and colonic carcinomas. Cancer Res. 1988;48:137-141
18 Shih C, Padhy LC, Murray M: Weinberg RA transforming genes of carcinonws and neuroblastomas introduced into mouse fibroblasts. Nature. 1981:290:261-264   DOI   ScienceOn
19 Choi G, Oh SC, Jung GW, Choi JO: Amplification and overexpression of Her-2/neu in salivery gland tumor. Korean J Otolaryngol. 1996:39:81-89
20 O-Charoenrat P, Rhys-Evans P, Archer DJ: C-erbB receptors in squamous cell carcinomas of the head and neck: Clinical significance and correlation with matrix metalloproteinases and vascular endothelial growth factors. Oral Oncol. 2002;38:73-80   DOI   ScienceOn